A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.

E. Ben-Josef,M. Schipper,I. Francis,S. Hadley,Randall Ten-Haken,T. Lawrence,D. Normolle,D. Simeone,C. Sonnenday,R. Abrams,W. Leslie,G. Khan,M. Zalupski
DOI: https://doi.org/10.1016/j.ijrobp.2012.02.051
2012-12-01
Abstract:
What problem does this paper attempt to address?